ÂÜÀòÂÒÂ×

The Drug Development Team at Acrivon is responsible for overseeing the entire lifecycle of targeted therapy development. This includes conducting advanced biomarker research, leading biology and drug discovery efforts, ensuring compliance with quality standards, managing chemistry manufacturing processes, navigating global regulatory requirements, and analyzing biostatistical data to optimize treatment efficacy. Their collaborative efforts aim to bring innovative therapies from concept to clinic, ultimately enhancing patient outcomes.